Approvals/TGA/JEMPERLI dostarlimab 500 mg concentrate for solution for infusion 10 mL vial

Approved

STANDARD

JEMPERLI dostarlimab 500 mg concentrate for solution for infusion 10 mL vial

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 58a669ae30227ded
Product Name: JEMPERLI dostarlimab 500 mg concentrate for solution for infusion 10 mL vial
Artg Id: 352631
Artg Name: JEMPERLI dostarlimab 500 mg concentrate for solution for infusion 10 mL vial
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2022-02-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/0c3ffd25f04e1d57df2f019345d04e81.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/210899dffbd7a2f50531a6412a0408c9.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

58a669ae30227ded

Type

Standard